CCM
PLRX icon

Cutter Capital Management’s Pliant Therapeutics PLRX Stock Holding History

Cutter Capital Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-194,119
Closed -$2.89M – 36
2024
Q1 		$2.89M Buy
+194,119
New +$3.2M 1.11% 24

Other funds holding PLRX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Cutter Capital Management's PLRX Position: Q2 2024 in Review

Cutter Capital Management sold out of Pliant Therapeutics (PLRX) in Q2 2024, closing a stake of 194,119 shares — an estimated $2.89M sold.

Cutter Capital Management first reported a position in PLRX in Q1 2024 and held it in 1 quarter. The position peaked at $2.89M in Q1 2024. 143 funds tracked by Wall St. Rank hold PLRX as of Q2 2024.

  • Cutter Capital Management reported no remaining Pliant Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Cutter Capital Management sold 194,119 Pliant Therapeutics shares in Q2 2024, an estimated $2.89M.
  • Cutter Capital Management first reported a position in Pliant Therapeutics in Q1 2024 and held it in 1 quarter.
  • Cutter Capital Management's Pliant Therapeutics position peaked at $2.89M in Q1 2024.
  • 143 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2024.

Based on Cutter Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.